Kelly G Sprankle

USPTO Granted Patents = 22 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 870(Granted Patents)

Company Filing History:

14 out of 1,035

Isis Pharmaceuticals, Inc.

patents

7 out of 39

Ambit Biosciences Corporation

patents

1 out of 1

Ambit Bioscience Corporation

patent

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2018

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10053430 - RAF kinase modulator compounds and methods of use thereof (2018-08-21),

2. 9730937 - RAF kinase modulator compounds and methods of use thereof (2017-08-15),

3. 9320739 - RAF kinase modulator compounds and methods of use thereof (2016-04-26),

4. 8969587 - RAF kinase modulator compounds and methods of use thereof (2015-03-03),

5. 8618289 - RAF kinase modulator compounds and methods of use thereof (2013-12-31),

6. 8557810 - Imidazolothiazole compounds for the treatment of disease (2013-10-15),

7. 8129374 - Method of using imidazolothiazole compounds for the treatment of disease (2012-03-06),

8. 7820657 - Imidazolothiazole compounds for the treatment of disease (2010-10-26),

9. 7223833 - Peptide nucleic acid conjugates (2007-05-29),

10. 6756199 - Peptide nucleic acid combinatorial libraries and improved methods of synthesis (2004-06-29),

11. 6750344 - Amine compounds and combinatorial libraries comprising same (2004-06-15),

12. 6642367 - Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom (2003-11-04),

13. 6316626 - Amine compounds and combinatorial libraries comprising same (2001-11-13),

14. 6222025 - Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom (2001-04-24),

15. 6204326 - PNA combinatorial libraries and improved methods of synthesis (2001-03-20),

Title: Kelly G Sprankle: A Pioneer in Innovation

Introduction:

Kelly G Sprankle, a visionary inventor based in Vista, CA (US), has established herself as a true pioneer in the field of inventions. With a passion for innovation and a dedication to pushing the boundaries of technology, her remarkable contributions continue to inspire future generations of inventors.

Latest Patents:

Kelly G Sprankle has an impressive track record with 22 patents to her name. Among her latest patents is the "RAF kinase modulator compounds and methods of use thereof." These compounds, compositions, and methods provide a novel approach to modulating the activity of RAF kinases, including BRAF kinase, for the treatment, prevention, or amelioration of diseases or disorders mediated by RAF kinases.

Career Highlights:

Throughout her career, Kelly G Sprankle has made significant contributions to the field of inventions. She has worked with prominent companies such as Isis Pharmaceuticals, Inc. and Ambit Biosciences Corporation, where she has played a key role in developing innovative solutions in the life sciences industry.

Collaborations:

Kelly G Sprankle has collaborated with esteemed professionals in the field, including coworkers like Phillip Dan Cook and Shripad S Bhagwat. These collaborations have led to groundbreaking discoveries and advancements in technology, further solidifying her reputation as a trailblazer in innovation.

Conclusion:

In conclusion, Kelly G Sprankle's relentless pursuit of innovation and her groundbreaking inventions have earned her a well-deserved place as a pioneer in the field. Her work continues to have a profound impact on the industry, shaping the future of technology and inspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.